These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1832367)

  • 1. Experience of long-term intraperitoneal insulin treatment using a new percutaneous access device.
    Wredling R; Adamson U; Lins PE; Backman L; Lundgren D
    Diabet Med; 1991 Jul; 8(6):597-600. PubMed ID: 1832367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?
    Giménez M; Purkayajtha S; Moscardó V; Conget I; Oliver N
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):182-184. PubMed ID: 29429951
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of abdominal location of the catheter on the efficacy of intraperitoneal insulin infusion using implantable and programmable pumps in type I diabetes.
    Pinget M; Jeandidier N; Keipes M; Louy S; Vetter A
    Transplant Proc; 1992 Jun; 24(3):945-6. PubMed ID: 1604676
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraperitoneal insulin absorption after long-term intraperitoneal insulin therapy.
    Scavini M; Pincelli A; Petrella G; Galimberti G; Zager PG; Torri M; Pozza G
    Diabetes Care; 1995 Jan; 18(1):56-9. PubMed ID: 7698048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter survival during long-term insulin therapy with an implanted programmable pump. The Implantable Insulin Pump Trial Study Group.
    Scavini M; Galli L; Reich S; Eaton RP; Charles MA; Dunn FL
    Diabetes Care; 1997 Apr; 20(4):610-3. PubMed ID: 9096988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Optimized Percutaneous Access System for CIPII.
    Garcia-Verdugo R; Erbach M; Schnell O
    J Diabetes Sci Technol; 2017 Jul; 11(4):814-821. PubMed ID: 28654300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with long-term peritoneal insulin infusion from external pumps.
    Selam JL; Slingeneyer A; Saeidi S; Mirouze J; Richard JL; Rodier M; Daynes B; Lapinski H
    Diabet Med; 1985 Jan; 2(1):41-4. PubMed ID: 2951065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal delivery of insulin via mechanical pump: surgical implications.
    Udelsman R; Boyne MS; Loman KE; Saudek CD
    Langenbecks Arch Surg; 2000 Oct; 385(6):367-72. PubMed ID: 11127519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for assessing catheter patency in implanted pumps for long-term intraperitoneal insulin delivery.
    Scavini M; Hammarberg B; Dosio F; Torri M; Petrella G; Galimberti G; Vai S; Fazio F; Pozza G
    Artif Organs; 1997 May; 21(5):405-8. PubMed ID: 9129773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients.
    Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
    Atherosclerosis; 2007 Oct; 194(2):342-7. PubMed ID: 17141785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with insulin analog lispro in IDDM with delayed absorption of subcutaneously applied human regular insulin and complicated intraperitoneal insulin infusion. A case report.
    Meier M; Brand J; Standl E; Schnell O
    Diabetes Care; 1998 Jul; 21(7):1044-5. PubMed ID: 9653592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates.
    van Bon AC; Dragt D; DeVries JH
    Diabetes Technol Ther; 2012 May; 14(5):447-8. PubMed ID: 22548715
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group.
    Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
    Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA
    Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.